Advances in the use of CRISPR-Cas9 and human induced pluripotent stem cell technologies to identify novel therapeutic targets for neurological disorders such as schizophrenia and addiction have been highlighted by researchers.

https://www.sciencedaily.com/releases/2017/11/171113095548.htm